Tasa de egreso hospitalario por hemorragia postparto en el periodo 2021-2024 en Chile

Rocío Alejandra Ponce Aracena; Esmeralda de Lourdes Parra Segovia; Paloma Javiera  Saldia Ponce; Javiera Cáceres Ortiz; Sebastián Mena Pereira

doi:10.5281/zenodo.23107190

Authors

Rocío Alejandra Ponce Aracena Médico Cirujano, CESFAM Miraflores, Viña del Mar, Chile Author https://orcid.org/0009-0003-1984-7578
Esmeralda de Lourdes Parra Segovia Interna de Medicina, Universidad Andrés Bello, Santiago, Chile Author https://orcid.org/0009-0002-6616-9872
Paloma Javiera Saldia Ponce Interna de Medicina, Universidad Autónoma de Chile, Santiago, Chile Author https://orcid.org/0009-0000-2833-4668
Javiera Cáceres Ortiz Interna de Medicina, Universidad Autónoma de Chile, Santiago, Chile Author https://orcid.org/0009-0003-9560-3137
Sebastián Mena Pereira Interno de Medicina, Universidad Autónoma de Chile, Santiago, Chile Author

DOI:

https://doi.org/10.5281/zenodo.23107190

Keywords:

Chile, Hospitalization, Postpartum Hemorrhage, Obstetrics

Abstract

Introduction: Background: Postpartum hemorrhage (PPH) is a major cause of maternal morbidity and mortality, and its recent hospital utilization in Chile has not been characterized nationally. We aimed to determine hospital discharge rates (HDR) for PPH between 2021 and 2024 by age, region, diagnostic subcategory, and length of stay. Methods: Observational, descriptive, retrospective study using public hospital discharge records of women aged 10–49 years with a primary diagnosis of PPH (ICD-10 O72). HDRs were expressed per 100,000 women, using denominators from the 2024 Census (national and age-specific) and National Institute of Statistics projections (regional). Results: There were 1,982 discharges (mean annual HDR 9.41), with annual variation (8.41–10.37). Women aged 20–39 years accounted for 89.56% of discharges and had the highest rates, and Los Ríos (20.17) and Los Lagos (15.96) had the highest regional HDRs. The most frequent subcategory was secondary or late PPH (39.35%), with a mean stay of 2.42 days, below the overall mean (3.10). Discussion: Rates showed no consistent pattern across years and were concentrated in one age group and two regions. Because the denominator is the female population, these differences are descriptive and do not imply greater obstetric risk. Conclusions: These results describe hospital utilization, not PPH incidence. They provide a baseline for surveillance and health planning and should be complemented with obstetric denominators and clinical variables.

Downloads

Download data is not yet available.

References

1. Jones J, Federspiel J, Eke C. Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone. Am J Obstet Gynecol MFM. 2023;5(2):100731. Disponible en: https://doi.org/10.1016/j.ajogmf.2022.100731

2. Wang M, Oyelese Y. Postpartum hemorrhage. Matern Fetal Med. 2024;6(3):180-188.

3. Bienstock J, Eke A, Hueppchen N. Postpartum hemorrhage. N Engl J Med. 2021;384(17):1635-1645. Disponible en: http://doi.org/10.1056/NEJMra1513247

4. Binyamin Y, Orbach-Zinger S, Heesen M. Current strategies for the diagnosis and management of postpartum hemorrhage: a focused review of four Cochrane Systematic Reviews. Int J Obstet Anesth. 2025;62:104692. Disponible en: http://doi.org/10.1016/j.ijoa.2025.104692

5. Organización Panamericana de la Salud. Estrategia para acelerar la reducción de la mortalidad materna en la Región de las Américas. Washington, D.C.: OPS; 2024.

6. Hofer S, Blaha J, Collins PW, et al. Haemostatic support in postpartum haemorrhage: A review of the literature and expert opinion. Eur J Anaesthesiol. 2023;40(2):120-131. Disponible en: https://doi.org/10.1097/EJA.0000000000001744

7. Aimagambetova G, Bapayeva G, Sakhipova G, Terzic M. Management of postpartum hemorrhage in low- and middle-income countries. J Clin Med. 2024;13(23):7387. Disponible en: https://doi.org/10.3390/jcm13237387

8. Organización Mundial de la Salud. Recomendaciones de la OMS para la prevención y el tratamiento de la hemorragia posparto. Ginebra: OMS; 2022.

9. Donoso E. La hemorragia obstétrica, la terapia transfusional y el principio de autonomía del paciente. Rev Chil Obstet Ginecol. 2006;71(4):227-228.

10. Donoso E, Carvajal J. El cambio del perfil epidemiológico de la mortalidad materna en Chile. Rev Med Chil. 2012;140(10):1253-1262. Disponible en: http://dx.doi.org/10.4067/S0034-98872012001000003

11. Departamento de Estadísticas e Información de Salud. Egresos hospitalarios. Datos abiertos [Internet]. Santiago: Ministerio de Salud de Chile; [citado 9 sep 2026].

12. Instituto Nacional de Estadísticas. Población censada por sexo y edad en grupos quinquenales: Censo 2024 [Internet]. Santiago: INE; 2025 [citado 9 sep 2026].

13. Instituto Nacional de Estadísticas. Estimaciones y proyecciones de la población de Chile 2002–2035: totales regionales, urbano y rural [Internet]. Santiago: INE; 2019 [citado 9 sep 2026].

14. Eminov E, Eminov A. Prevalencia del embarazo adolescente y evaluación de los resultados del embarazo. Arch Gynecol Obstet. 2025;311(2):401-409. Disponible en: https://doi.org/10.1007/s00404-025-07931-w

15. Benavides-Nachimba LL, Ramos-Argilagos ME, Donoso-Noroña RF. Factores asociados a hemorragia materna por atonía uterina en postparto inmediato. Salud Vida. 2025;9(2):100-112. Disponible en: https://doi.org/10.35381/s.v.v9i2.4718

16. Carducci ME, Izbizky G. La edad materna avanzada como factor de riesgo de resultados maternos y perinatales adversos. Rev Fac Cien Med Univ Nac Córdoba. 2024;81(1):45-52. Disponible en: https://doi.org/10.31053/1853.0605.v81.n1.41447

17. Marshall A, Durani U, Bartley A, et al. The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality. Am J Obstet Gynecol. 2017;217(3):344.e1-344.e6. Disponible en: http://doi.org/10.1016/j.ajog.2017.05.00